Spots Global Cancer Trial Database for synta
Every month we try and update this database with for synta cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | NCT01031225 | Non Small Cell ... | STA 9090 | 18 Years - | Synta Pharmaceuticals Corp. | |
| A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia | NCT00964873 | Acute Myeloid L... Acute Lymphobla... Blast-phase Chr... AML ALL CML | STA-9090 (ganet... | 18 Years - | Synta Pharmaceuticals Corp. | |
| A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | NCT01031225 | Non Small Cell ... | STA 9090 | 18 Years - | Synta Pharmaceuticals Corp. | |
| STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders | NCT00858572 | AML CML MDS Myeloproliferat... | STA-9090 (ganet... | 18 Years - | Synta Pharmaceuticals Corp. | |
| A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | NCT01031225 | Non Small Cell ... | STA 9090 | 18 Years - | Synta Pharmaceuticals Corp. | |
| STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders | NCT00858572 | AML CML MDS Myeloproliferat... | STA-9090 (ganet... | 18 Years - | Synta Pharmaceuticals Corp. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
